DHR Valuation Metrics
DHR Stock Price Metrics
DHR Dividend Metrics
DHR Growth Rate Metrics
DHR Discounted Cash Flow Metrics
| Fair Value Price | $219.62 |
| Margin of Safety | 19.09% |
DHR Revenue Metrics
DHR PE Ratio Metrics
| PE Ratio | 35.67 |
| PE Ratio Avg TTM | 41.62 |
| PE Ratio Avg 3Y | 38.62 |
| Current VS TTM Avg | -14.29% |
| Current VS 3Y Avg | -7.64% |
| Current VS 5Y Avg | +2.08% |
DHR PS Ratio Metrics
| PS Ratio | 5.29 |
| PS Ratio Avg TTM | 6.02 |
| PS Ratio Avg 3Y | 6.59 |
| Current VS TTM Avg | -12.09% |
| Current VS 3Y Avg | -19.71% |
| Current VS 5Y Avg | -17.69% |
DHR PB Ratio Metrics
| PB Ratio | 2.48 |
| PB Ratio Avg TTM | 2.82 |
| PB Ratio Avg 3Y | 3.16 |
| Current VS TTM Avg | -12.00% |
| Current VS 3Y Avg | -21.53% |
| Current VS 5Y Avg | -28.65% |
DHR Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 24.79 |
| PFCF Ratio Avg TTM | 29.02 |
| PFCF Ratio Avg 3Y | 29.69 |
| Current VS TTM Avg | -14.58% |
| Current VS 3Y Avg | -16.50% |
| Current VS 5Y Avg | -11.45% |
DHR Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.35 |
| Debt/Equity Ratio Avg TTM | 0.35 |
| Debt/Equity Ratio Avg 3Y | 0.37 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | -5.41% |
| Current VS 5Y Avg | -17.97% |
DHR PEG Ratio Metrics
| PEG Ratio | 89.17 |
| PEG Ratio Avg TTM | 89.17 |
| PEG Ratio Avg 3Y | 89.17 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
DHR FCF Yield
| FCF Yield | 4.03% |
| FCF Yield Avg TTM | 3.49% |
| FCF Yield Avg 3Y | 3.47% |
| Current VS TTM Avg | +15.56% |
| Current VS 3Y Avg | +16.10% |
| Current VS 5Y Avg | +9.75% |
DHR Earnings Yield
| Earnings Yield | 2.80% |
| Earnings Yield Avg TTM | 2.43% |
| Earnings Yield Avg 3Y | 2.72% |
| Current VS TTM Avg | +15.08% |
| Current VS 3Y Avg | +3.10% |
| Current VS 5Y Avg | -7.56% |
DHR EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 27.72 |
| Ev/Ebit Ratio Avg TTM | 30.65 |
| Ev/Ebit Ratio Avg 3Y | 32.50 |
| Current VS TTM Avg | -9.55% |
| Current VS 3Y Avg | -14.72% |
| Current VS 5Y Avg | -6.62% |
DHR EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 21.52 |
| Ev/Ebitda Ratio Avg TTM | 23.46 |
| Ev/Ebitda Ratio Avg 3Y | 23.88 |
| Current VS TTM Avg | -8.28% |
| Current VS 3Y Avg | -9.87% |
| Current VS 5Y Avg | -3.76% |
DHR EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.72 |
| Ev/Assets Ratio Avg TTM | 1.98 |
| Ev/Assets Ratio Avg 3Y | 2.16 |
| Current VS TTM Avg | -13.17% |
| Current VS 3Y Avg | -20.48% |
| Current VS 5Y Avg | -23.83% |
DHR EV/Sales Ratio Metrics
| Ev/Sales Ratio | 5.81 |
| Ev/Sales Ratio Avg TTM | 6.63 |
| Ev/Sales Ratio Avg 3Y | 7.16 |
| Current VS TTM Avg | -12.35% |
| Current VS 3Y Avg | -18.88% |
| Current VS 5Y Avg | -16.96% |
DHR Current Ratio Metrics
| Current Ratio | 1.87 |
| Current Ratio Avg TTM | 1.64 |
| Current Ratio Avg 3Y | 1.71 |
| Current VS TTM Avg | +14.37% |
| Current VS 3Y Avg | +9.36% |
| Current VS 5Y Avg | +10.76% |
DHR Quick Ratio Metrics
| Quick Ratio | 1.51 |
| Quick Ratio Avg TTM | 1.28 |
| Quick Ratio Avg 3Y | 1.37 |
| Current VS TTM Avg | +17.97% |
| Current VS 3Y Avg | +10.02% |
| Current VS 5Y Avg | +11.44% |
DHR ROIC Metrics
| ROIC | 5.72% |
| ROIC Avg 3Y | 6.54% |
| ROIC Avg 5Y | 6.70% |
| Current VS 3Y Avg | -12.57% |
| Current VS 5Y Avg | -14.58% |
| Current VS 10Y Avg | -6.65% |
DHR Return on Assets Metrics
| ROA | 4.33 |
| ROA Avg TTM | 4.68 |
| ROA Avg 3Y | 5.89 |
| Current VS TTM Avg | -7.48% |
| Current VS 3Y Avg | -26.45% |
| Current VS 5Y Avg | -27.97% |
DHR Return on Equity Metrics
| ROE | 6.88 |
| ROE Avg TTM | 7.38 |
| ROE Avg 3Y | 9.51 |
| Current VS TTM Avg | -6.71% |
| Current VS 3Y Avg | -27.67% |
| Current VS 5Y Avg | -32.83% |
DHR Net Profit Margin Metrics
| Net Profit Margin | 14.71% |
| Net Profit Margin Avg TTM | 15.52% |
| Net Profit Margin Avg 3Y | 19.51% |
| Current VS TTM Avg | -5.22% |
| Current VS 3Y Avg | -24.60% |
| Current VS 5Y Avg | -24.07% |
Last Updated: Wednesday, June 10, 2026
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair